Should Lantus (insulin glargine) be refrigerated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Lantus should be refrigerated when not in use to maintain its potency and prevent degradation. When considering the storage of Lantus, it's crucial to follow specific guidelines to ensure the medication remains effective. According to the study published in Diabetes Care 1, vials of insulin not in use should be refrigerated to prevent loss of potency, clumping, frosting, or precipitation. Key points to consider for the storage of Lantus include:

  • Refrigeration at temperatures between 36°F and 46°F (2°C and 8°C) when not in use
  • Avoiding extreme temperatures (<36 or >86°F, <2 or >30°C) and excess agitation
  • Keeping insulin in use at room temperature to limit local irritation at the injection site
  • Discarding opened insulin after a certain period, as specified by the manufacturer, to ensure potency
  • Always checking the appearance of Lantus before use, ensuring it is clear and colorless, and not using it if it appears cloudy, discolored, or contains particles. It's essential to prioritize the patient's safety and the medication's efficacy by adhering to these storage guidelines, as supported by the study 1.

From the FDA Drug Label

Unopened (not in-use) Insulin Glargine vials Store unused Insulin Glargine vials in the refrigerator from 36°F to 46°F (2°C to 8°C) After Insulin Glargine vials have been opened (in-use) Store in-use (opened) Insulin Glargine vials in a refrigerator from 36°F to 46°F (2°C to 8°C) or at room temperature below 86°F (30°C) for up to 28 days.

Storage of Lantus: Lantus (Insulin Glargine) should be refrigerated at a temperature between 36°F to 46°F (2°C to 8°C) when unopened. After opening, it can be stored in the refrigerator or at room temperature below 86°F (30°C) for up to 28 days 2.

From the Research

Storage Requirements for Lantus

  • Lantus is a type of insulin glargine, which is a long-acting basal insulin analogue.
  • According to the study 3, acceptable storage information for products requiring storage at temperatures below room temperature was compiled, but it does not specifically mention Lantus.
  • However, it is generally recommended to store insulin glargine in the refrigerator at a temperature between 2°C and 8°C (36°F and 46°F) until the expiration date or until opened.
  • Once opened, insulin glargine can be stored at room temperature (up to 25°C or 77°F) for a certain period, usually up to 28 days, but this may vary depending on the specific product and manufacturer's instructions.

Comparison with Other Insulin Analogues

  • Studies 4, 5, and 6 compared the efficacy and safety of different long-acting insulin analogues, including insulin glargine, insulin detemir, and insulin degludec.
  • These studies did not specifically address the storage requirements for Lantus, but they provided information on the pharmacological properties and clinical outcomes of these insulin analogues.
  • Another study 7 found that switching from twice-daily glargine or detemir to once-daily degludec improved glucose control in type 1 diabetes, but it did not discuss storage requirements.

Conclusion on Storage Requirements

  • Based on the available evidence, it is recommended to store Lantus in the refrigerator until opened and to follow the manufacturer's instructions for storage after opening.
  • However, the studies provided do not offer specific guidance on the storage requirements for Lantus, and it is essential to consult the product label or manufacturer's instructions for detailed information.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Allowable room temperature excursions for refrigerated medications: A 20-year review.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2022

Research

Insulin detemir versus insulin glargine for type 2 diabetes mellitus.

The Cochrane database of systematic reviews, 2011

Research

Effects of switching from insulin glargine or detemir to insulin degludec in patients with type 1 diabetes mellitus.

Diabetes therapy : research, treatment and education of diabetes and related disorders, 2013

Related Questions

What is a suitable alternative and dosage for a patient currently on Glargine (insulin glargine) 15-0-10, who weighs 85 kg, given the unavailability of Glargine (insulin glargine)?
What is the appropriate starting dose of insulin in a patient with type 2 diabetes mellitus (T2DM) and impaired glycemic control, as evidenced by a hemoglobin A1c (HbA1c) level of 14%, in the setting of liver failure?
What is the average age of diagnosis for Type 1 Diabetes Mellitus (T1DM)?
What are the basal insulin dosing guidelines for a 70-kilogram patient with diabetes?
At what creatinine level should oral antidiabetics be discontinued and insulin therapy initiated in patients with diabetes due to impaired renal function?
Are there studies suggesting increased fertility rates immediately after removal of ovarian endometriomas (endometriotic cysts)?
What are the treatment options for Nephrolithiasis (Kidney Stones)?
What is the appropriate workup for a patient with nephrolithiasis (kidney stones)?
What is the cause of left lower quadrant abdominal tenderness in a 54-year-old male with a history of hypertension and Irritable Bowel Syndrome (IBS), diarrhea-predominant, who presents with abdominal discomfort and flatulence after eating a normal diet, without hematochezia, mucus in stool, nausea, vomiting, or fever, and has a recent normal colonoscopy except for a polyp, and takes dicyclomine (Bentyl) for IBS?
What should a patient be told about their blood work results, which include a positive Antinuclear Antibody (ANA) test, a negative ANA Indirect Fluorescent Antibody (IFA) test, normal testosterone levels, low bilirubin, elevated Alanine Transaminase (ALT), presence of immature granulocytes, and a negative Rh (Rhesus) factor?
Can Repatha (evolocumab) be taken with other medications?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.